Editorial
doi: 10.1016/j.eururo.2014.05.006.
Epub 2014 May 27.
New insights into subtypes of invasive bladder cancer: considerations of the clinician
Affiliations
- PMID: 24877661
- DOI: 10.1016/j.eururo.2014.05.006
Item in Clipboard
Editorial
New insights into subtypes of invasive bladder cancer: considerations of the clinician
Eur Urol.
2014 Oct.
No abstract available
Comment in
-
Re: David J. McConkey, Woonyoung Choi, Colin P.N. Dinney. New insights into subtypes of invasive bladder cancer: considerations of the clinician. Eur Urol 2014;66:609-10.Eur Urol. 2015 Apr;67(4):e73-5. doi: 10.1016/j.eururo.2014.08.063. Epub 2014 Sep 4. Eur Urol. 2015. PMID: 25194907 No abstract available.
-
Reply to Mattias Aine, Fredrik Liedberg, Gottfrid Sjödahl, and Mattias Höglund's Letter to the Editor re: David J. McConkey, Woonyoung Choi, Colin P.N. Dinney. New insights into subtypes of invasive bladder cancer: considerations of the clinician. Eur Urol 2014;66:609-10.Eur Urol. 2015 Apr;67(4):e76-8. doi: 10.1016/j.eururo.2014.08.064. Epub 2014 Sep 6. Eur Urol. 2015. PMID: 25199718 No abstract available.
Similar articles
-
Retrospective analysis of the efficacy of two cycles of M-VAC neoadjuvant chemotherapy followed by radical cystectomy for muscle-invasive bladder cancer.Anticancer Res. 2013 Oct;33(10):4497-503. Anticancer Res. 2013. PMID: 24123021
-
Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancer.J Urol. 2005 Jul;174(1):80-5. doi: 10.1097/01.ju.0000162018.40891.ba. J Urol. 2005. PMID: 15947583
-
Can patient selection for bladder preservation be based on response to chemotherapy?Cancer. 2003 Apr 1;97(7):1644-52. doi: 10.1002/cncr.11232. Cancer. 2003. PMID: 12655521 Clinical Trial.
-
Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.Urology. 2004 Sep;64(3):488-93. doi: 10.1016/j.urology.2004.04.088. Urology. 2004. PMID: 15351577 Review.
-
Recent advances in treatment of advanced urothelial carcinoma.Curr Urol Rep. 2012 Apr;13(2):147-52. doi: 10.1007/s11934-012-0238-0. Curr Urol Rep. 2012. PMID: 22367511 Free PMC article. Review.
Cited by
-
Naturally Occurring Canine Invasive Urinary Bladder Cancer: A Complementary Animal Model to Improve the Success Rate in Human Clinical Trials of New Cancer Drugs.Int J Genomics. 2017;2017:6589529. doi: 10.1155/2017/6589529. Epub 2017 Apr 9. Int J Genomics. 2017. PMID: 28487862 Free PMC article. Review.
-
Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening.Oncotarget. 2018 May 25;9(40):25935-25945. doi: 10.18632/oncotarget.25407. eCollection 2018 May 25. Oncotarget. 2018. PMID: 29899832 Free PMC article.
-
Comprehensive immune transcriptomic analysis in bladder cancer reveals subtype specific immune gene expression patterns of prognostic relevance.Oncotarget. 2017 Aug 9;8(41):70982-71001. doi: 10.18632/oncotarget.20237. eCollection 2017 Sep 19. Oncotarget. 2017. PMID: 29050337 Free PMC article.
-
Molecular Subtypes of Bladder Cancer.Curr Oncol Rep. 2018 Aug 20;20(10):77. doi: 10.1007/s11912-018-0727-5. Curr Oncol Rep. 2018. PMID: 30128829 Review.
-
Smoking intensity and bladder cancer aggressiveness at diagnosis.PLoS One. 2018 Mar 23;13(3):e0194039. doi: 10.1371/journal.pone.0194039. eCollection 2018. PLoS One. 2018. PMID: 29570711 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
